Pomalidomide/Cyclophosphamide/Prednisone for Relapsed/Refractory MM


Pomalidomide/Cyclophosphamide/Prednisone for Relapsed/Refractory MM
Slides from a presentation at ASH 2012 and transcribed comments from a recent interview with A Keith Stewart, MBChB (1/9/13)
Palumbo A et al. Pomalidomide cyclophosphamide and prednisone (PCP) treatment for relapsed/refractory multiple myeloma. Proc ASH 2012;Abstract 446.

Dr Stewart is Dean for Research at the Mayo Clinic in Arizona, is Consultant in the Division of Hematology/Oncology and holds the Vasek and Anna Maria Polak Professorship in Cancer Research in Scottsdale, Arizona.